A Comparative Bioavailability Study of Two Torasemide 10 mg Tablets Formulations in Healthy Adult Participants Under Fasting Conditions:

NCT07201584 ↗

Phase 1 Recruiting 26 enrolled Berlin-Chemie Menarini

RandomizedCrossoverOpen-labelOther

Summary

The purpose of this study is to evaluate the bioavailability, safety and tolerability of Torasemide 10 mg tablets (Berlin-Chemie AG), compared to Unat® 10 tablets (Viatris Healthcare GmbH) in healthy adult participants under fasting conditions.

Timeline

Start: 2025-09-05
Primary completion: 2025-12-30
Completion: 2026-04-01

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Torasemide	Unknown	10 mg	—

Indications

No indication recorded.